Prime Medicine, Inc. (PRME): Insider Trading, Congress Trades & Research | Tormere

PRME

$4.65+4.49%visit website

Prime Medicine, Inc.

Market Cap

$843M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

2.08

48mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

21.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	1,225	838
Research & development	43,990	34,709	34,105	33,397	146,201
Total operating expenses	55,198	49,446	51,510	44,439	200,593
Operating income	(53,973)	(48,608)	(50,654)	(43,285)	(196,520)
Net income	(50,582)	(46,079)	(49,122)	(42,109)	(187,892)
EPS (basic) ($)	(0.32)		(0.28)	(0.24)	(1.05)
EPS (diluted) ($)	(0.32)		(0.28)	(0.24)	(1.05)
Weighted avg. shares (basic)	160,503		177,096	177,225
Weighted avg. shares (diluted)	160,503		177,096	177,225

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 16 more quarters, back to Sep 2021, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

20 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2025-08-01	2025-08-05	GV 2021 GP, L.L.C.	10% Owner	Purchase	1.50M	$3.30	$4.95M	3.26M	View

Reporting Insiders

Recent News

Prime Medicine, Inc. (PRME) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-06

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates

Yahoo · 2026-11-05

Democrats Sweep Midterms: What It Means For Pharma And Biotech Holdings (Stocks To Watch)

SeekingAlpha · 2026-11-05

Prime Focus shares drop 7% as Ramayana Part 1 makes debut across 5,510 shows today

The Economic Times · 2026-11-05

Prime Medicine, Inc. (PRME) Surges 23.2%: Is This an Indication of Further Gains?

Yahoo · 2026-10-29

PRME, BEAM, EDIT, NTLA, CRSP Stocks Gain As FDA Signals Faster Route For Patient-Specific Gene Edits

Yahoo · 2026-10-28

Prime Medicine (NASDAQ:PRME) Stock Price Up 7.1% - Here's What Happened

MarketBeat · 2026-10-27

Prime Medicine (NASDAQ:PRME) Stock Price Down 8.1% - Here's Why

MarketBeat · 2026-10-23

Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why

Yahoo · 2026-10-12

Leading Indicators For The October Breakout Cycle

SeekingAlpha · 2026-10-11

Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

Benzinga · 2026-10-09

Prime Medicine (PRME) Stock Draws Traders On FDA Trial Wins

Timothy Sykes · 2026-10-06

PRME Stock Dips As Prime Medicine Faces Steep Losses

StocksToTrade · 2026-09-25

Prime Medicine stock surges on FDA IND clearance

Yahoo Finance · 2026-09-24

CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?

Yahoo Finance · 2026-09-23

Informational purposes only, not investment advice.